Purple Biotech Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
PPBT
IL0007650166
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.59M 50.48M 18.59M |
---|---|---|---|---|---|
Net income 2024 * | -13M -48.28M -17.78M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.6% |
Managers | Title | Age | Since |
---|---|---|---|
Gil Efron
CEO | Chief Executive Officer | 57 | 18-10-10 |
Lior Fhima
DFI | Director of Finance/CFO | - | 22-11-01 |
Ido Morpurgo
COO | Chief Operating Officer | 51 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rowinsky
CHM | Chairman | 67 | 19-10-01 |
Yael Margolin
BRD | Director/Board Member | 70 | 12-19 |
Simcha Rock
BRD | Director/Board Member | 73 | 13-07-10 |
1st Jan change | Capi. | |
---|---|---|
+4.85% | 109B | |
+11.44% | 105B | |
-0.35% | 22.25B | |
-12.10% | 22.09B | |
-8.00% | 18.68B | |
-38.36% | 17.58B | |
-10.16% | 16.85B | |
+4.58% | 13.76B | |
+35.75% | 12.46B |